Gad Gilad, PhD

Dr. Gad Gilad, the co-founder and CEO of Gilad&Gilad, LLC (www.ForNerveHealth.com), received his PhD in neurobiology and behavior from Cornell University. His research focus is the response of the nervous system to stress, neurotrauma and neurodegenerative diseases, and the development of new therapeutics. His collaboration with Varda H. Gilad while working at several academic centers, including the National Institutes of Health, Weizmann Institute of Science and Harvard University, resulted in more than 100 peer-reviewed scientific papers and several patents. One of their main discoveries is the neuroprotective properties of agmatine.

Previous Articles

A Nutraceutical for Neuropathies: Agmatine
March 1, 2018 (Vol. 36, Issue 03)
Trending
News / Profession
NBCE-FCLB Merger Approved
NBCE-FCLB Merger Approved

The proposed merger of the National Board of Chiropractic Examiners and Federation of Chiropractic Licensing Boards was approved by NBCE delegates and FCLB members at their respective annual meetings, held jointly in Atlanta, Ga., this year. Per the new bylaws, the new entity takes the NBCE name, with FCLB continuing as a department within NBCE. The federation will continue to enjoy Board of Directors representation on what will be a single, expanded board.

 |  Digital Exclusive
Dynamic Chiropractic Staff
Diagnosis & Diagnostic Equip
When Radiculopathy Isn’t Radiculopathy: A Clinical Series (Pt. 3)
When Radiculopathy Isn’t Radiculopathy

Before introducing subscapularis syndrome as an upper extremity analog, it is essential to revisit piriformis syndrome as a well-established example of myogenic pseudo-radiculopathy. Piriformis syndrome has long served as a clinical exception to disc-centric models of lower extremity pain and provides an important framework for understanding how deep muscular dysfunction can mimic radiculopathy in the absence of nerve root compression.

Ken Kaufman, DC
Healthcare / Public Health
From Pain Scores to Performance Metrics
From Pain Scores to Performance Metrics

Pain has become the dominant language of musculoskeletal healthcare. Numeric pain-rating scales and symptom reports are routinely used as primary indicators of clinical success. But while pain reduction is meaningful, it is an incomplete and often misleading representation of recovery. This has real consequences for patient adherence, long-term outcomes, and how conservative care is perceived within the broader healthcare system.

Christopher Proulx, DC, PhD(ABD), CSCS